Inovio Pharmaceuticals
INO
#9427
Rank
NZ$0.16 B
Marketcap
NZ$2.02
Share price
2.59%
Change (1 day)
-30.27%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.89. In 2024 the company made an earnings per share (EPS) of NZ-$6.71 an increase over its 2023 EPS that were of NZ-$10.35.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-28.42%
2024NZ-$6.71-35.14%
2023NZ-$10.35-56.62%
2022NZ-$23.86-19.54%
2021NZ-$29.6535.9%
2020NZ-$21.82-11.57%
2019NZ-$24.6715.24%
2018NZ-$21.41-2.78%
2017NZ-$22.026.93%
2016NZ-$20.59134.88%
2015NZ-$8.77-29.51%
2014NZ-$12.44-57.34%
2013NZ-$29.16146.55%
2012NZ-$11.8320.83%
2011NZ-$9.79-29.41%
2010NZ-$13.87-48.48%
2009NZ-$26.9210%
2008NZ-$24.4711.11%
2007NZ-$22.02-41.3%
2006NZ-$37.52-66.91%
2005NZ-$113.37110.61%
2004NZ-$53.83-61.63%
2003NZ-$140.29186.67%
2002NZ-$48.94
2001N/A-100%
2000NZ-$39.15-63.64%
1999NZ-$107.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.93-486.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.23-350.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.64-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.42-353.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.40-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$0.59-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA